QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
LON:DOCS

Dr. Martens (DOCS) Share Forecast, Price & News

GBX 135.50
-2.60 (-1.88%)
(As of 10/3/2023 ET)
Compare
Today's Range
135.50
▼
139.50
50-Day Range
135.90
▼
159.80
52-Week Range
113
▼
295.21
Volume
1.69 million shs
Average Volume
2.04 million shs
Market Capitalization
£1.34 billion
P/E Ratio
1,042.31
Dividend Yield
4.43%
Price Target
GBX 221.25
ProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlines

Dr. Martens MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
63.3% Upside
GBX 221.25 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
£40.01 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.44 out of 5 stars

See Top Rated MarketRank™ Stocks Here

DOCS stock logo

About Dr. Martens (LON:DOCS) Stock

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

DOCS Price History

DOCS Stock News Headlines

September 27, 2023 | americanbankingnews.com
Dr. Martens (LON:DOCS) Trading 1.3% Higher
September 26, 2023 | yahoo.com
Editors’ picks: 15 things Yahoo staffers tried and loved in September
October 3, 2023 | Oxford Club (Ad)
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.
September 21, 2023 | msn.com
Game Commission may release 300 American martens in Pennsylvania, pending public review
September 15, 2023 | msn.com
Bootmaker Dr Martens to offer shoe repairs in sustainability push
September 11, 2023 | msn.com
10 Doc Marten dupes that will get you more boot for your buck
September 6, 2023 | ca.style.yahoo.com
Dr. Martens boots are a celebrity staple for fall — and we have the proof
August 23, 2023 | yahoo.com
Woman uses unique hack to break in Doc Marten boots without wearing them
October 3, 2023 | Legacy Research (Ad)
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
August 15, 2023 | uk.investing.com
Dr. Martens PLC (DOCS)
August 8, 2023 | msn.com
How Dr. Martens’ Adrian Loafers Became TikTok’s Favourite Slip-Ons
August 8, 2023 | uk.movies.yahoo.com
A shrewd insider is buying this FTSE 250 stock
August 3, 2023 | msn.com
Gen Z fashion trends are shaking up the office. From Doc Martens to pocket squares, here's what 11 workers are wearing this summer.
August 2, 2023 | uk.news.yahoo.com
With an activist on board, is it time to buy Dr. Martens shares?
August 2, 2023 | msn.com
Dr. Martens Highlights Artistic Redesigns: Celebrating Gender Diversity
August 1, 2023 | msn.com
Dr Martens slammed over boots showing person with breast removal scars
August 1, 2023 | dailymail.co.uk
The 'immoral' brands pushing body mutilation on girls: How Costa Coffee, Oxfam, Dr Martens and Penguin Books have used cartoon images to 'trivialise' life-changing trans 'top ...
July 31, 2023 | msn.com
Doc Martens spotlights 'alarming' DIY shoes promoting gender transition 'top surgery'
July 31, 2023 | msn.com
Dr. Martens stock leads European gains after report of activist investor buying
July 31, 2023 | msn.com
Activist fund Sparta builds stake in Dr Martens after share price slump
July 31, 2023 | msn.com
Bootmaker Dr Martens gains on report of stake building by activist investor
July 27, 2023 | bizjournals.com
Dr. Martens to target American sales after regional struggles
July 25, 2023 | msn.com
Down 26% in 2023, is the Dr Martens share price a screaming buy signal?
July 24, 2023 | msn.com
Should I buy Dr Martens shares today?
July 18, 2023 | finance.yahoo.com
Dr. Martens plc's (LON:DOCS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
July 11, 2023 | msn.com
Dr. Marten’s Drop to the Lowest Price of The Year on Amazon (Up to 40% Off)
June 16, 2023 | finance.yahoo.com
Retailers Are Trying to Fix Their Supply-Chain Forecasts
See More Headlines
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

DOCS Company Calendar

Ex-Dividend for 7/18 Dividend
6/08/2023
Dividend Payable
7/18/2023
Today
10/03/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Footwear & Accessories
Sub-Industry
N/A
Sector
Consumer Cyclical
Current Symbol
LON:DOCS
CUSIP
N/A
CIK
N/A
Web
www.drmartensplc.com
Phone
44 12 1415 7047
Fax
N/A
Employees
2,591
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 221.25
High Stock Price Forecast
GBX 350
Low Stock Price Forecast
GBX 175
Forecasted Upside/Downside
+62.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
GBX 0.13
Trailing P/E Ratio
1,045.38
Forward P/E Ratio
12.57
P/E Growth
0.04
Net Income
£128.90 million
Net Margins
12.89%
Pretax Margin
N/A
Return on Equity
35.20%
Return on Assets
12.88%

Debt

Debt-to-Equity Ratio
110.29
Current Ratio
3.09
Quick Ratio
1.13

Sales & Book Value

Annual Sales
£1 billion
Price / Sales
1.34
Cash Flow
GBX 9.51 per share
Price / Cash Flow
14.29
Book Value
GBX 40 per share
Price / Book
3.40

Miscellaneous

Outstanding Shares
988,400,000
Free Float
N/A
Market Cap
£1.34 billion
Optionable
Not Optionable
Beta
0.07
10 Best Stocks to Own in 2023 Cover
10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Kenneth Wilson (Age 56)
    CEO & Director
    Comp: $773k
  • Mr. Jon William Mortimore (Age 56)
    CFO & Director
    Comp: $503k
  • Mr. Geert Peeters (Age 57)
    Chief Operating Officer
  • Mr. Ronald Garricks
    Chief Information Officer
  • Ms. Meg Johnson
    Chief Marketing Officer
  • Ms. Emily Clare Reichwald (Age 48)
    Chief People & Sustainability Officer and Company Sec.
  • Mr. Sean O'Neill
    Chief Digital Officer
  • Mr. Derek Chan
    Pres of APAC
  • Mr. Adam M. Meek
    Chief Product Officer
  • Ms. Jennifer Somer
    Pres of Americas

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













DOCS Stock - Frequently Asked Questions

Should I buy or sell Dr. Martens stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DOCS shares.
View DOCS analyst ratings or view top-rated stocks.

What is Dr. Martens' stock price forecast for 2023?

4 Wall Street research analysts have issued 12 month price targets for Dr. Martens' shares. Their DOCS share price forecasts range from GBX 175 to GBX 350. On average, they expect the company's stock price to reach GBX 221.25 in the next twelve months. This suggests a possible upside of 62.8% from the stock's current price.
View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2023?

Dr. Martens' stock was trading at GBX 190.60 at the start of the year. Since then, DOCS stock has decreased by 28.7% and is now trading at GBX 135.90.
View the best growth stocks for 2023 here.

How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens?

Dr. Martens declared a dividend on Thursday, June 1st. Investors of record on Thursday, June 8th will be given a dividend of GBX 4.28 per share on Tuesday, July 18th. This represents a yield of 2.74%. The ex-dividend date is Thursday, June 8th. This is a boost from the stock's previous dividend of GBX 1.56. The official announcement can be seen at this link.
Read our dividend analysis for DOCS.

Is Dr. Martens a good dividend stock?

Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 4.13%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,615.38%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for DOCS.

What is Dr. Martens' stock symbol?

Dr. Martens trades on the London Stock Exchange (LON) under the ticker symbol "DOCS."

How do I buy shares of Dr. Martens?

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Dr. Martens' stock price today?

One share of DOCS stock can currently be purchased for approximately GBX 135.90.

How much money does Dr. Martens make?

Dr. Martens (LON:DOCS) has a market capitalization of £1.34 billion and generates £1 billion in revenue each year. The company earns £128.90 million in net income (profit) each year or GBX 0.13 on an earnings per share basis.

How many employees does Dr. Martens have?

The company employs 2,591 workers across the globe.

How can I contact Dr. Martens?

Dr. Martens' mailing address is 28 Jamestown Road, Camden, London NW1 7BY, United Kingdom. The official website for the company is www.drmartensplc.com. The company can be reached via phone at 44 12 1415 7047.

This page (LON:DOCS) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -